|
|
|||||||||||
The British Journal of Psychiatry 159: 572-573 (1991)
© 1991 The Royal College of Psychiatrists
LS Chong and PM Abbott
Fazakerley Hospital, Liverpool.
Loxapine was introduced to the British market two years ago although it has been used in North America for eight years. We report the first probable case of neuroleptic malignant syndrome (NMS) secondary to loxapine in Britain. Two previous cases have been reported in North America (manufacturer's data).
This article has been cited by other articles:
![]() |
S. R. White Acute Dystonic Reaction and the Neuroleptic Malignant Syndrome Journal of Pharmacy Practice, June 1, 2005; 18(3): 175 - 187. [Abstract] [PDF] |
||||
![]() |
G. J. Chandran, J. R. Mikler, and D. L. Keegan Neuroleptic malignant syndrome: case report and discussion Can. Med. Assoc. J., September 2, 2003; 169(5): 439 - 442. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Psychiatric Bulletin | Advances in Psychiatric Treatment | All RCPsych Journals |